Mississippi State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mississippi State University sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 1 currently recruiting 3 completed early-phase tilt upper quartile by trial count

Mississippi State University: 5 sponsored US clinical trials, 1 recruiting.

Mississippi State University sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hoarding Disorder, with 1 trials.

Upper-quartile sponsor footprint

Mississippi State University sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Mississippi State University pipeline

1 recruiting of 5 indexed (20% open); 3 completed (60%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Hoarding Disorder (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Mississippi State University: open-pipeline peers nationwide

Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

Mississippi State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4.95.05.055.05.05.1 0%5%10%15%20%25% Total trials Recruiting share Mississippi State University4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAlign TechnologyAltruBioAlvernia UniversityAmazentis
Mississippi State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Mississippi State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this Mississippi State University page

5 registered trials is a research-attention snapshot, not an endorsement of Mississippi State University or any single study.

  • 1 of Mississippi State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hoarding Disorder is the condition Mississippi State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hoarding Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Mississippi State University pipeline card: 5 registered trials from official public datasets.Report a data error.